Cancer Biology
ISSN:
2150-1041 (print); ISSN: 2150-105X (online),
doi prefix:10.7537,
Quarterly
Volume 13 / Issue 4, Cumulated No. 52, December 25, 2023
Cover (jpg), Cover (pdf), Introduction, Contents, cbj1304
The
following manuscripts are presented as online first for
peer-review, starting from
December 2, 2023.
All
comments are welcome:
editor@sciencepub.net
or contact with
author(s) directly.
You can use the message in end of the article abstract to
cite it.
To get Microsoft Documents: After you open the "Full Text" for each
article, change the last 3 characters of the web address from .pdf
to .doc (or .docx)
When you submit manuscript(s),
please mention that it is submitted to the Cancer Biology.
Marsland Press, 310 W 18th
Street, New York, NY 10011, USA.
718-404-5362, 347-321-7172
http://www.cancerbio.net
CONTENTS
No.
|
Titles /
Authors /Abstracts
|
Full Text
|
No.
|
1
|
awareness AND perception towards the utilization of cervical
cancer screening (CCS) SERVICES among nurses in A TEACHING
Hospital in Ibadan, Nigeria
Akinpelu A.O1
1 Department of
Health and Information Management Lead City University Ibadan,
Nigeria
Agboola O.A 2
2 Department of
Microbiology Lead City University Ibadan, Nigeria
Umezurike E.T 2*
2 Department of
Microbiology Lead City University Ibadan, Nigeria
* Contact of
Corresponding Author-
No. 1 Otudeko Drive
Toll Gate Area Ibadan Oyo State
+2348135939991
umezurikee@yahoo.com
ABSTRACT:
Invasive
cervical cancer is the second-most common cancer in women
world-wide, 80% of these cases were discovered through records
to be from developing countries Although it can be readily
detected in the premalignant phase, cervical cancer remains the
second most common cancer in Nigeria and fifth in the United
Kingdom. The objective of this study is to determine awareness
and perception affecting utilization of cervical cancer
screening services awareness, perception and factors affecting
utilization of cervical cancer screening services among nurses
in Adeoyo Maternity Teaching Hospital, Ibadan, Oyo State,
Nigeria. The research was a descriptive and cross-sectional
study conducted in
Adeoyo Maternity
Teaching Hospital Ibadan,
Nigeria. The study showed a high level of perception 106 (59.9%)
among the nurses within this study and the nurses that had
positive perception only 8 (19.0%) had undergone cervical cancer
screening in the past.
Their knowledge of cervical cancer was not poor; 97.7% of the
respondents have heard of cervical cancer screening as a form of
cervical cancer prevention and 168 (94.9%) are familiar with the
age range (between 16-65 years old) that are eligible to go for
CCS, only 128 (72.3%) were aware of modern day CCS equipment
under Oyo state hospital management board facilities. However
only 16 (9.0%) have worked in CCS unit and only 8 (4.5%) had
privileged to attend refresher course training to enhance their
knowledge of CCS practice.
The findings of
this study show that majority of the Nurses at Adeoyo Maternity
Teaching Hospital though they are aware yet only few have
undergone cervical cancer screening.
[kinpelu A. O.
Agboola O.A.
Umezurike
E.T.
awareness AND perception towards the utilization of cervical cancer
screening (CCS) SERVICES among nurses in A TEACHING Hospital in
Ibadan, Nigeria.Cancer
Biology 2023;13(4):1-5].
ISSN: 2150-1041 (print); ISSN: 2150-105X (online).
http://www.cancerbio.net
01.doi:10.7537/marscbj130423.01.
KEYWORDS: Nurses, Cervical Cancer, Screening, Awareness,
Perception |
Full Text |
1
|
2
|
Research Literatures of Cancer
Prevention
Dr.
Mark Herbert
World Development Institute
39-06 Main Street, Flushing,
Queens, New York 11354, USA,
ma708090@gmail.com
Abstract:
Cancer is the general name for a group of more than 100
diseases. Although there are many kinds of cancer, all cancers
start because abnormal cells grow out of control. Untreated
cancers can cause serious illness and death. The body is made up
of trillions of living cells. Normal body cells grow, divide,
and die in an orderly fashion. During the early years of a
person’s life, normal cells divide faster to allow the person to
grow. After the person becomes an adult, most cells divide only
to replace worn-out or dying cells or to repair injuries. This
article introduces recent research reports as references in the
related studies.
[Dr.
Mark Herbert.
Research Literatures of Cancer Prevention. Cancer Biology
2023;13(4):6-31]. ISSN: 2150-1041 (print); ISSN: 2150-105X
(online).
http://www.cancerbio.net
02.doi:10.7537/marscbj130423.02.
Key words:
cancer; life; research; literature; cell |
Full Text |
2
|
3
|
Research Literatures of New
Ideas in Cancer Treatment
Dr.
Mark Herbert
World Development Institute
39-06 Main Street, Flushing,
Queens, New York 11354, USA,
ma708090@gmail.com
Abstract:
Cancer is the general name for a group of more than 100
diseases. Although there are many kinds of cancer, all cancers
start because abnormal cells grow out of control. Untreated
cancers can cause serious illness and death. The body is made up
of trillions of living cells. Normal body cells grow, divide,
and die in an orderly fashion. During the early years of a
person’s life, normal cells divide faster to allow the person to
grow. After the person becomes an adult, most cells divide only
to replace worn-out or dying cells or to repair injuries. This
article introduces recent research reports as references in the
related studies.
[Dr.
Mark Herbert.
Research Literatures of Cancer Prevention.Cancer Biology
2023;13(4):32-85]. ISSN: 2150-1041 (print); ISSN: 2150-105X
(online).
http://www.cancerbio.net
03.doi:10.7537/marscbj130423.03.
Key words:
cancer; life; research; literature; cell |
Full Text |
3
|
4 |
Clinicopathological Features
of Non Hodgkin’s
Lymphoma Patients
Treated in Kasr Al-Ainy Centre of
Clinical Oncology (Nemrock) from
2015 to 2020
Wedad B. Hashem, MD, Rasha
Salama MD, Hadir Habib, Msc, Hamdy Zawam MD
Department of Clinical Oncology,
Kasr Al-Ainy School of medicine, Cairo University, Egypt
E-mail:
weedo_82@hotmail.com
Abstract: Background:
Worldwide, non-Hodgkin lymphoma (NHL) is the most prevalent
hematologic cancer. It has more than 40 major subtypes. The
primary
objective of this
study is
to evaluate
the prevalence
and
clinicopathological
features of
different
types of
NHL and
to study the
impact of number of
cycles of
Rituximab on
progression
free survival of
DLBCL patients. Our
main secondary
objective is
to assess
the incidence
of CNS relapse
in DLBCL.
Methods:
This is a five-year retrospective (from January 2015 till
January 2020) study of
clinic-pathological features of NHL patients
in Kasr Aini Clinical Oncology department, Cairo
University. Final analysis of DLBCL patients data was done.
Results:
During the
period from
January 2015
to January 2020
data of
lymphoid
malignancies retrieved were
719 cases.
Meanwhile among NHL, the diffuse
large B cell lymphoma (DLBCL) was the commonest subtype
forming 43% (251
patients). Only 186 patients of DLBCL were eligible for the
final analysis. In our cohort, the median age at diagnosis was
50 years. We have found that patients with intermediate or high
CNS-IPI were more likely to develop CNS relapse with a
trend toward
statistical significance (p=
0.08). Complete remission (CR) also increased to 60.1% of
the patients after
adding rituximab to CHOP. Median PFS for patients who achieved
CR after first line of
treatment was 13.5 months, while those who failed to
achieve a
response had
a median PFS
of 5 months,
with p
value <0.0001.
Overall survival was significantly affected by the response
after 1st
line of
chemotherapy;
with the
median OS
for those
who achieved
favorable response was 20.8 versus 8.1 months for those
who achieved no
response after
completion of
the first
line of
chemotherapy.
Conclusion:
The most prevalent lymphoma subtype in our study, accounting for
43% of the patients, was DLBCL. When added to chemotherapy,
rituximab improved both CR and ORR. Furthermore, Rituximab plus
chemotherapy had a noticeably longer overall survival.
Regarding CNS relapse and the
impact of CNS IPI, we noticed that patients with intermediate or
high CNS-IPI were at a higher risk of experiencing CNS relapse.
[Wedad B. Hashem, Rasha Salama,
Hadir Habib, Hamdy Zawam.
Clinicopathological Features of
Non Hodgkin’s Lymphoma Patients
Treated in Kasr Al-Ainy Centre of
Clinical Oncology (Nemrock) from
2015 to 2020.
Cancer Biology
2023;13(4):86-93]. ISSN: 2150-1041 (print); ISSN: 2150-105X
(online).
http://www.cancerbio.net
04.doi:10.7537/marscbj130423.04.
Keyword:
DLBCL, Rituximab, CNS prophylaxis |
Full Text |
4 |
The manuscripts in this
issue were presented as online first for peer-review starting
from
December 2, 2023.
All comments are
welcome:
editor@sciencepub.net
For
back issues of the Researcher,
click here.
Emails:
editor@sciencepub.net
|